U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C30H47N5O2
Molecular Weight 509.7265
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of UNC-0638

SMILES

COC1=CC2=C(NC3CCN(CC3)C(C)C)N=C(N=C2C=C1OCCCN4CCCC4)C5CCCCC5

InChI

InChIKey=QOECJCJVIMVJGX-UHFFFAOYSA-N
InChI=1S/C30H47N5O2/c1-22(2)35-17-12-24(13-18-35)31-30-25-20-27(36-3)28(37-19-9-16-34-14-7-8-15-34)21-26(25)32-29(33-30)23-10-5-4-6-11-23/h20-24H,4-19H2,1-3H3,(H,31,32,33)

HIDE SMILES / InChI

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/24102134

UNC-0638, an inhibitor of G9a and GLP with excellent potency and selectivity over a wide range of epigenetic and non-epigenetic targets. UNC-0638 treatment of a variety of cell lines resulted in lower global H3K9me2 levels, equivalent to levels observed for small hairpin RNA knockdown of G9a and GLP with the functional potency of UNC-0638 being well separated from its toxicity. UNC0638 markedly reduced the clonogenicity of MCF7 cells, reduced the abundance of H3K9me2 marks at promoters of known G9a-regulated endogenous genes and disproportionately affected several genomic loci encoding microRNAs. In mouse embryonic stem cells, UNC-0638 reactivated G9a-silenced genes and a retroviral reporter gene in a concentration-dependent manner without promoting differentiation. UNC-0638 is not suitable for animal studies due to its poor pharmacokinetic (PK) properties.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolines.
2011-09-08
A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells.
2011-07-10
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In MDA-MB-231 cells, UNC-0638 (48 h exposure) reduced H3K9me2 levels in a concentration-dependent manner with an IC50 of 81 ± 9 nM. UNC-0638 had high potency, ranging from 48 to 238 nM, in reducing H3K9me2 levels in breast, prostate, colon carcinomas and normal fibroblast cells, with the two prostate carcinoma cell lines, PC3 (IC50 = 59 nM) and 22RV1 (IC50 = 48 nM), being the most sensitive
Name Type Language
UNC0638
Preferred Name English
UNC-0638
Common Name English
4-QUINAZOLINAMINE, 2-CYCLOHEXYL-6-METHOXY-N-(1-(1-METHYLETHYL)-4-PIPERIDINYL)-7-(3-(1-PYRROLIDINYL)PROPOXY)-
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID30154787
Created by admin on Mon Mar 31 21:28:33 GMT 2025 , Edited by admin on Mon Mar 31 21:28:33 GMT 2025
PRIMARY
CAS
1255580-76-7
Created by admin on Mon Mar 31 21:28:33 GMT 2025 , Edited by admin on Mon Mar 31 21:28:33 GMT 2025
PRIMARY
PUBCHEM
46224516
Created by admin on Mon Mar 31 21:28:33 GMT 2025 , Edited by admin on Mon Mar 31 21:28:33 GMT 2025
PRIMARY
FDA UNII
26A103L2FO
Created by admin on Mon Mar 31 21:28:33 GMT 2025 , Edited by admin on Mon Mar 31 21:28:33 GMT 2025
PRIMARY